1. 607TiPBIG BANG study: A multicenter phase II study of the MEK inhibitor binimetinib + BRAF inhibitor encorafenib + anti-EGFR antibody cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer (EPOC 1703). (23rd October 2018) Authors: Kotani, D; Bando, H; Masuishi, T; Komatsu, Y; Yamaguchi, K; Nakajima, T E; Satoh, T; Nishina, T; Esaki, T; Nomura, S; Sakamoto, S; Iida, S; Matsuda, S; Yonemura, M; Fuse, N; Sato, A; Fujii, S; Ebi, H; Ohtsu, A; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 608TiPBRAVERY study: A multicenter phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer (EPOC1701). (23rd October 2018) Authors: Masuishi, T; Taniguchi, H; Kotani, D; Bando, H; Komatsu, Y; Yamaguchi, K; Nakajima, T E; Satoh, T; Nishina, T; Esaki, T; Wakabayashi, M; Nomura, S; Sakamoto, S; Ono, H; Hirano, N; Fujishiro, N; Fuse, N; Sato, A; Ohtsu, A; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 659PAvelumab (anti–PD-L1) in Japanese patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC): Updated results from the phase Ib JAVELIN solid tumour JPN trial. (23rd October 2018) Authors: Doi, T; Iwasa, S; Muro, K; Satoh, T; Hironaka, S; Esaki, T; Nishina, T; Hara, H; Machida, N; Komatsu, Y; Shimada, Y; Otsu, S; Shimizu, S; Chand, V; Watanabe, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Intrahepatic cysts in biliary atresia after successful hepatoportoenterostomy. Issue 3 (March 1984) Authors: Saito, S; Nishina, T; Tsuchida, Y Journal: Archives of disease in childhood Issue: Volume 59:Issue 3(1984) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O-005A multicentre, prospective clinical evaluation study for analyzing RAS mutational status utilizing plasma circulating tumor DNA in patients with metastatic colorectal cancer. (20th June 2018) Authors: Kagawa, Y; Kato, T; Bando, H; Akagi, K; Denda, T; Nishina, T; Komatsu, Y; Oki, E; Kudo, T; Yamanaka, T; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O-017SUNRISE-DI study: decision impact of the 12-gene recurrence score (12-RS) assay on adjuvant chemotherapy recommendation for stage II and IIIA/B colon cancer. (2nd July 2019) Authors: Watanabe, J; Sato, T; Kagawa, Y; Oki, E; Kuboki, Y; Ikeda, M; Ueno, H; Kato, T; Kusumoto, T; Masuishi, T; Yamaguchi, K; Kanazawa, A; Nishina, T; Uetake, H; Yamanaka, T; Yoshino, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SO-001Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as the second-line treatment in patients with advanced gastric cancer. (2nd July 2019) Authors: Kadowaki, S; Izawa, N; Minashi, K; Nishina, T; Yamanaka, T; Muro, K; Sunakawa, Y; Hironaka, S; Kajiwara, T; Kawakami, Y; Nakajima, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗